Tumori Journal

Papers
(The median citation count of Tumori Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Small tongue squamous cell carcinoma with neck metastasis at diagnosis: operative insights and surgical technique55
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer39
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis28
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort28
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval26
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age14
Blooming in the rain13
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide13
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis13
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach13
Chemo-surgical approach in vulvar leiomyosarcoma: A case report11
Oral vinorelbine in young patients with desmoid-type fibromatosis10
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients10
Ongoing discussion: Is prophylactic central neck dissection necessary in c T 1a-b,2 N 0 papilla10
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma9
Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testing8
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network8
Expression of concern8
Advances in spatial multi-omics in tumors7
Humanistic nursing combined with Neuman’s nursing in the application for oncology patients7
Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy7
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-20177
Prognostic value of Aurora B expression in cancer patients: A meta-analysis7
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization6
ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma6
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients6
Adherence to oral hormonal anticancer agents in breast cancer6
Quality assurance for cancer patient safety: Clinical assessment for precise angles in linac during radiation therapy6
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study6
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series6
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report5
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects5
Personalized treatment using predictive biomarkers in solid organ malignancies: A review5
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes5
15th BGICC Abstract Book 20235
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC5
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease5
KRAS inhibitors in drug resistance and potential for combination therapy5
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer5
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study5
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update5
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?4
Current practices of follow-up programs for childhood cancer survivors in Italy4
AIOM Abstract4
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology4
Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report4
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience4
Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis4
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?4
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation4
I was only sixteen4
End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance4
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series3
Implementation of a MSRE ddPCR method for the detection of methylated WIF1 and NPY genes in colorectal cancer patients3
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs3
De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?3
Italian translation, cultural adaptation and pilot testing of Psychosocial Assessment Tool (PAT 3.1) in pediatric cancer3
The digital revolution in pathology: Towards a smarter approach to research and treatment3
Differences in clinical features and prognosis between orbit adenoid cystic carcinoma and adenocarcinoma: a study from the SEER 18 database3
Increased expression of FGF14 and SCN2A/SCN11A is associated with better survival of HCC patients3
Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup3
Corrigendum to “Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study”3
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization3
BGICC Conference Abstract Book 20223
Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models3
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study3
COVID-19 immunization in people with cancer—Is it safe and efficient? What do we know?3
Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scores3
ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China3
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic review3
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making3
A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy3
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice3
Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data2
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study2
Mind the gap with Europe. Why public interest cannot be a good reason to perform observational and epidemiological research?2
Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events2
Can Ki-67 predict radiotherapy response in neuroendocrine tumors? Retrospective analysis of a monocentric series of patients2
Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group2
Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey2
Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey2
Prevalence of breast cancer in ovarian cancer patients and its impact on patient survival: An analysis of the surveillance, epidemiology, and end results data2
The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations2
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments2
The challenges of cascade genetic testing in hereditary cancer syndromes: A few ethical considerations2
A shared vaccination ambulatory for patients with cancer in Udine, Italy2
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching2
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting2
A five-year review of chemoradiotherapy practice in anal cancer: Radiotherapy audit results from a cancer centre in Wales, UK2
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers2
BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer2
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey2
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy2
Factors influencing the colorectal surveillance adherence in Lynch Syndrome: A retrospective monocentric study2
European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team2
Associations between vascular endothelial growth factor polymorphisms and response to 5-FU-based pharmaceutical therapy in esophageal squamous cell carcinoma: A meta-analysis2
Effects of uniportal 3D video-assisted thoracic surgery lobectomy on postoperative pain and immune function in patients with NSCLC2
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund2
The impact of the new European CTR on academic clinical research: A survey by the Italian Sarcoma Group Federated Trial Centre2
Risk-based breast cancer screening: What are the challenges?2
Delphi Study on the creation of a Committee of patients, caregivers, and representatives of patient associations2
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report2
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study1
Postoperative radiotherapy for stage IV breast cancer following primary tumor removal: Systematic review and meta-analysis1
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis1
Two years after the reform of Italian Ethics Committees: Time for reflection1
Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data1
A homogeneous treatment for non-DIPG diffuse midline glioma1
Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis1
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report1
Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options1
Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma1
A molecular reappraisal of matrix-producing breast metaplastic carcinoma highlighted by PLAG1 and MYC rearrangements1
The last journey, coming home before dying for migrant cancer patients: A case series1
There is no such a thing as a ‘biological’ basis for cancer disparities: A call to end misreporting of the ultimate determinants of health outcomes1
Get up, stand up: Alongside adolescents and young adults with cancer for their right to be forgotten1
Clinical application and prospect of MRD evaluation in lung cancer based on ctDNA level: A review1
Corrigendum to “Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure”1
Patients with brain metastases from gastric cancer1
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)1
HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination1
The role of diet as adjuvant treatment in FAP patients1
North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy1
Clinical difference between solitary and multiple pulmonary adenocarcinoma nodules1
A look towards the clonal origin of metastatic pulmonary carcinosarcoma: Report of a patient with an unexpected long-term survival1
LDCT-based lung cancer screening and small cell lung cancer: Limited but non-negligible impact on survival. A brief report1
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro t1
Predicting severe toxicity after head-and-neck cancer RT: Validation of the synergist role of a biological marker and dosimetry1
Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysis1
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib1
Comparison of breast cancer surgery cases in urban and rural areas: Clinical factors and patient-reported outcomes1
Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib1
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis1
Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression1
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia1
Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes1
Association between clinical factors and the choice of palliative care setting among cancer patients: A post-hoc analysis of a cohort study1
AIOM Abstract1
AIOM Abstract1
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria1
Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?1
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial1
Association of APOC1 levels and nutritional indices with clinicopathological features and prognostic value in patients with DLBCL1
Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib1
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences?1
0.30324912071228